The 4,000-year-old drug, most commonly used to treat pain, prevents certain tumours from forming and spreading across the body – findings that are already changing health policies.

Scientists from the University of Cambridge have made an unexpected discovery about a medicine that many people already have ...

Short-term low-dose aspirin use prior to immunochemical fecal occult blood testing (iFOBT) significantly increased the test’s sensitivity for detecting advanced colorectal tumors, new study findings ...

In January, St. Helena Hospital began using a device recently FDA-approved, that determines if aspirin therapy is beneficial for a patient, called VerifyNow. While multiple studies and clinical trials ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A recent study has revealed that an aspirin a day may stop cancer from spreading. In 2025, over 2 million new cancer ...

The test targets a potential U.S. market of over 60 million individuals and a potential global market exceeding 200 million individuals who take aspirin regularly. Physicians and laboratories ...

New research has revealed important information about how aspirin works. Even though this drug has been available commercially since the late 1800s, scientists have not yet fully elucidated its ...